Original Article

Accepting Myocardial Infarction Diagnosis as an Important Challenge During Transition Process: A Qualitative Study

Abstract

Background & Aim: The increasing prevalence of myocardial infarction has turned this disease into a global epidemic. With the diagnosis of myocardial infarction and health-illness transition, changes are made in a person's life. Special attention is needed to manage non-acceptance of a newly diagnosed disease and achieve a healthy transition. This study was conducted with the aim of investigating the causes of acceptance or non-acceptance of the first myocardial infarction.

Methods & Materials: This qualitative study utilized the directed content analysis approach based on Meleis transition theory. Data were collected between June 2023 and January 2024 through in-depth, semi-structured individual interviews with 11 participants selected through purposive sampling. Data analysis followed the three-step method proposed by Elo and Kyngas.

Results: The analysis revealed four main categories: Nature of Transition, Transition Condition, Patterns of Response and Nursing Therapeutics. In this study, the transition condition is discussed.

Conclusion: Illness Acceptance is accepting the possible problems that may happen due to getting sick and then starting a new life. In the meantime, it is necessary to improve some of the factors that affect the level of acceptance of a person and facilitate acceptance and reduce the obstacles as much as possible.

IssueArticles in Press QRcode
SectionOriginal Article(s)
Keywords
Key Words: Myocardial Infarction Transition Acceptance of Disease Qualitative Research

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Khorrami Estakhri R, Taheri Ezbarami Z, Peyrovi H, Kazemnezhad Leyli E, Isanazar A, Fakhrmousavi SA, Jafaraghaee F. Accepting Myocardial Infarction Diagnosis as an Important Challenge During Transition Process: A Qualitative Study. NPT. 2025;:X-X.